Circumventing the Impossible: Cell-Free Synthesis of Protein Toxins for Medical and Diagnostic Applications.

Alina Mai Woelbern, Franziska Ramm
Author Information
  1. Alina Mai Woelbern: Fraunhofer Institute for Cell Therapy and Immunology, Branch Bioanalytics and Bioprocesses (IZI-BB), Am M��hlenberg 13, 14476 Potsdam, Germany.
  2. Franziska Ramm: Fraunhofer Institute for Cell Therapy and Immunology, Branch Bioanalytics and Bioprocesses (IZI-BB), Am M��hlenberg 13, 14476 Potsdam, Germany.

Abstract

Naturally occurring protein toxins can derive from bacteria, fungi, plants, and animal venom. Traditionally, toxins are known for their destructive effects on host cells. Despite, and sometimes even because of, these harmful effects, toxins have been used for medical benefits. The prerequisite for the development of toxin-based medications or treatments against toxins is thorough knowledge about the toxin and its underlying mechanism of action. Thus, the toxin of interest must be synthesized. Traditional cell-based production requires high laboratory safety standards and often results in a low total protein yield due to the toxin's harmful, cytotoxic nature. These drawbacks can be circumvented by using cell-free protein synthesis (CFPS), a highly adaptable platform technology relying on cell lysates rather than living cells. This review discusses the current advances in cell-free synthesis of protein toxins as well as their uses and applications for pharmaceutical and diagnostic purposes.

Keywords

References

  1. Cell Microbiol. 2008 May;10(5):1130-9 [PMID: 18201245]
  2. Toxins (Basel). 2024 Apr 10;16(4): [PMID: 38668610]
  3. Sci Rep. 2023 Jul 28;13(1):12271 [PMID: 37507457]
  4. Sci Rep. 2017 Sep 20;7(1):12030 [PMID: 28931913]
  5. Proc Natl Acad Sci U S A. 1974 Jan;71(1):11-5 [PMID: 4204202]
  6. Methods Mol Biol. 2014;1118:17-33 [PMID: 24395407]
  7. Toxins (Basel). 2022 Mar 23;14(4): [PMID: 35448842]
  8. J Biol Chem. 1994 Jan 28;269(4):2652-8 [PMID: 8300596]
  9. Sci Rep. 2017 Sep 15;7(1):11710 [PMID: 28916746]
  10. PLoS One. 2015 Mar 23;10(3):e0118559 [PMID: 25799574]
  11. Microbiome Res Rep. 2023 Jul 20;2(4):28 [PMID: 38045926]
  12. Nucleic Acids Res. 1992 Oct 11;20(19):4987-95 [PMID: 1383935]
  13. Nature. 1980 Apr 3;284(5755):473-4 [PMID: 6987540]
  14. Blood. 1998 Jan 15;91(2):399-405 [PMID: 9427692]
  15. Toxins (Basel). 2021 Aug 18;13(8): [PMID: 34437446]
  16. Front Mol Biosci. 2022 Apr 14;9:832379 [PMID: 35586195]
  17. Toxins (Basel). 2023 May 24;15(6): [PMID: 37368657]
  18. Sci Rep. 2024 Mar 13;14(1):6043 [PMID: 38472311]
  19. Front Bioeng Biotechnol. 2020 Sep 28;8:1031 [PMID: 33117774]
  20. Microbiology (Reading). 2004 Dec;150(Pt 12):3959-67 [PMID: 15583149]
  21. Microbiology (Reading). 2022 Mar;168(3): [PMID: 35333704]
  22. Molecules. 2021 Apr 12;26(8): [PMID: 33921462]
  23. Appl Microbiol Biotechnol. 2016 Feb;100(4):1597-1610 [PMID: 26685676]
  24. Trends Biotechnol. 2005 Mar;23(3):150-6 [PMID: 15734558]
  25. Proc Natl Acad Sci U S A. 1978 Feb;75(2):701-4 [PMID: 273232]
  26. Toxins (Basel). 2021 Feb 09;13(2): [PMID: 33572271]
  27. EXS. 2010;100:1-29 [PMID: 20358680]
  28. Biochem Biophys Res Commun. 1961 Apr 28;4:404-8 [PMID: 13768264]
  29. Front Bioeng Biotechnol. 2022 Apr 29;10:873906 [PMID: 35573244]
  30. Protein Expr Purif. 2012 Aug;84(2):173-80 [PMID: 22626528]
  31. PLoS One. 2013 Dec 20;8(12):e82234 [PMID: 24376523]
  32. Protein Expr Purif. 2009 Dec;68(2):128-36 [PMID: 19664715]
  33. Front Bioeng Biotechnol. 2022 Jan 20;9:811905 [PMID: 35127675]
  34. Biol Rev Camb Philos Soc. 2014 May;89(2):450-65 [PMID: 24102715]
  35. Toxicon. 1985;23(2):289-305 [PMID: 4024139]
  36. FEMS Microbiol Lett. 1999 Aug 15;177(2):225-9 [PMID: 10474188]
  37. Biotechnol Bioeng. 2014 Jan;111(1):25-36 [PMID: 24018795]
  38. Biotechnol J. 2016 Feb;11(2):274-81 [PMID: 26380966]
  39. Proc Natl Acad Sci U S A. 2002 Nov 12;99(23):14652-7 [PMID: 12409616]
  40. Biotechnol Adv. 2012 Sep-Oct;30(5):1185-94 [PMID: 22008973]
  41. EMBO Rep. 2017 Sep;18(9):1490-1492 [PMID: 28743713]
  42. Nat Commun. 2020 Apr 20;11(1):1872 [PMID: 32312991]
  43. Toxins (Basel). 2021 Nov 15;13(11): [PMID: 34822591]
  44. Toxins (Basel). 2010 Feb 1;2(2):215-228 [PMID: 20871837]
  45. Toxins (Basel). 2021 Jun 11;13(6): [PMID: 34207957]
  46. Cell. 2001 Mar 23;104(6):937-48 [PMID: 11290330]
  47. Toxins (Basel). 2022 Jan 16;14(1): [PMID: 35051039]
  48. Methods Protoc. 2019 Mar 12;2(1): [PMID: 31164605]
  49. Toxicon. 2013 Dec 15;76:132-42 [PMID: 24060377]
  50. Toxins (Basel). 2017 Mar 16;9(3): [PMID: 28300784]
  51. Nat Commun. 2014 Sep 29;5:4897 [PMID: 25263813]
  52. J Biol Chem. 1979 Jul 10;254(13):5855-61 [PMID: 221485]
  53. Nat Chem Eng. 2024 Jan;1(1):97-107 [PMID: 38468718]
  54. Toxicon. 2015 Dec 15;108:226-31 [PMID: 26428390]
  55. Nature. 1989 Jan 5;337(6202):93-6 [PMID: 2909895]
  56. Eng Life Sci. 2018 Feb;18(2):140-148 [PMID: 29497355]
  57. Front Cell Infect Microbiol. 2012 Apr 17;2:52 [PMID: 22919643]
  58. Sci Rep. 2020 Feb 19;10(1):2887 [PMID: 32076011]
  59. N Biotechnol. 2016 Jun 25;33(4):480-7 [PMID: 27085957]
  60. Emerg Infect Dis. 1999 Mar-Apr;5(2):224-34 [PMID: 10221874]
  61. Nat Commun. 2015 Feb 05;6:6198 [PMID: 25652783]
  62. Methods Enzymol. 2000;326:245-54 [PMID: 11036646]
  63. ACS Synth Biol. 2023 Apr 21;12(4):1216-1226 [PMID: 36940255]
  64. J Biochem. 1973 Aug;74(2):285-96 [PMID: 4586675]
  65. Protein Expr Purif. 2011 Jan;75(1):15-20 [PMID: 20851769]
  66. Protein Eng. 2000 Aug;13(8):575-81 [PMID: 10964987]
  67. Lab Chip. 2016 Jan 21;16(2):269-81 [PMID: 26554896]
  68. J Pharm Sci. 2020 Jan;109(1):104-115 [PMID: 31669121]
  69. Curr Protoc Protein Sci. 2011 Apr;Chapter 27:Unit27.2 [PMID: 21488044]
  70. Acta Naturae. 2021 Jul-Sep;13(3):4-14 [PMID: 34707893]
  71. Eur J Biochem. 1976 Aug 1;67(1):247-56 [PMID: 823012]
  72. Cell Mol Biol (Noisy-le-grand). 1996 Jun;42(4):461-71 [PMID: 8828901]
  73. FEBS J. 2006 Sep;273(18):4141-53 [PMID: 16930130]
  74. Virulence. 2013 Nov 15;4(8):774-84 [PMID: 24071927]
  75. Amino Acids. 2016 Sep;48(9):2205-14 [PMID: 27209197]
  76. Proc Natl Acad Sci U S A. 2000 Jan 18;97(2):559-64 [PMID: 10639118]
  77. Nat Rev Cancer. 2008 Jun;8(6):473-80 [PMID: 18469827]
  78. Sci Rep. 2017 Jun 1;7(1):2653 [PMID: 28572615]
  79. Toxicol In Vitro. 2023 Mar;87:105537 [PMID: 36535555]
  80. Bioconjug Chem. 2014 Feb 19;25(2):351-61 [PMID: 24437342]
  81. Biochemistry. 2001 Jul 24;40(29):8514-22 [PMID: 11456489]
  82. ACS Omega. 2022 Jul 11;7(28):24111-24120 [PMID: 35874267]
  83. Nat Rev Drug Discov. 2003 Oct;2(10):790-802 [PMID: 14526382]
  84. Biomolecules. 2021 Oct 02;11(10): [PMID: 34680080]
  85. AAPS J. 2006 Aug 18;8(3):E532-51 [PMID: 17025272]
  86. Int J Mol Sci. 2022 Nov 08;23(22): [PMID: 36430170]
  87. Toxins (Basel). 2010 Apr;2(4):683-737 [PMID: 22069606]
  88. Clin Cancer Res. 2009 Feb 1;15(3):832-9 [PMID: 19188153]
  89. Front Bioeng Biotechnol. 2019 Dec 20;7:420 [PMID: 31921823]
  90. Toxins (Basel). 2019 Jan 08;11(1): [PMID: 30626031]
  91. Biochim Biophys Acta. 2011 Jan;1808(1):271-8 [PMID: 20692229]
  92. PLoS One. 2016 Oct 21;11(10):e0165137 [PMID: 27768741]
  93. Chembiochem. 2015 Nov;16(17):2420-31 [PMID: 26478227]
  94. Int J Mol Sci. 2024 Jul 29;25(15): [PMID: 39125859]
  95. Clin Vaccine Immunol. 2010 May;17(5):784-92 [PMID: 20357058]
  96. Biotechnol Bioeng. 2023 Oct;120(10):2890-2906 [PMID: 37376851]
  97. J Biol Chem. 1993 Mar 5;268(7):5302-8 [PMID: 8444903]
  98. Toxicon. 2011 Feb;57(2):199-207 [PMID: 21112350]
  99. J Drug Target. 2021 Sep;29(8):848-862 [PMID: 33615933]
  100. Clin Cancer Res. 2000 Feb;6(2):326-34 [PMID: 10690507]
  101. Eur J Biochem. 1984 Dec 3;145(2):279-82 [PMID: 6548708]
  102. Proc Natl Acad Sci U S A. 1977 Mar;74(3):975-8 [PMID: 265590]
  103. Front Microbiol. 2024 Feb 20;15:1370818 [PMID: 38444801]
  104. Int J Mol Sci. 2023 Mar 27;24(7): [PMID: 37047271]
  105. Sci Rep. 2015 Mar 02;5:8663 [PMID: 25727242]
  106. Sci Rep. 2018 Jun 4;8(1):8514 [PMID: 29867209]
  107. Toxins (Basel). 2021 Jan 22;13(2): [PMID: 33499082]

Grants

  1. SME 40-06962/Fraunhofer Society

MeSH Term

Animals
Humans
Cell-Free System
Protein Biosynthesis
Toxins, Biological
Diagnostic Services

Chemicals

Toxins, Biological

Word Cloud

Created with Highcharts 10.0.0toxinsproteincell-freesynthesiscaneffectscellsharmfultoxinNaturallyoccurringderivebacteriafungiplantsanimalvenomTraditionallyknowndestructivehostDespitesometimesevenusedmedicalbenefitsprerequisitedevelopmenttoxin-basedmedicationstreatmentsthoroughknowledgeunderlyingmechanismactionThusinterestmustsynthesizedTraditionalcell-basedproductionrequireshighlaboratorysafetystandardsoftenresultslowtotalyieldduetoxin'scytotoxicnaturedrawbackscircumventedusingCFPShighlyadaptableplatformtechnologyrelyingcelllysatesratherlivingreviewdiscussescurrentadvanceswellusesapplicationspharmaceuticaldiagnosticpurposesCircumventingImpossible:Cell-FreeSynthesisProteinToxinsMedicalDiagnosticApplicationsvitrotranslationvenoms

Similar Articles

Cited By